Impact BioMedical, Inc. (IBO) — Financial Flexibility Index
Impact BioMedical, Inc. (IBO) has a Financial Flexibility Index of -0.07x as of September 2025. Free cash flow of $-1.99 Million (operating CF $-1.99 Million minus capex $0.00) represents 0% of total liabilities ($27.06 Million). Check Impact BioMedical, Inc. cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Impact BioMedical, Inc. Financial Flexibility Index (2017–2024)
Historical Financial Flexibility Index trend for Impact BioMedical, Inc. across 8 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of Impact BioMedical, Inc..
Annual Financial Flexibility Index for Impact BioMedical, Inc. (2017–2024)
Year-by-year free cash flow to debt coverage for Impact BioMedical, Inc.. Explore IBO operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.43x | $-5.64 Million | $-5.64 Million | $13.05 Million | ▼ -149.5% |
| 2023 | -0.17x | $-2.83 Million | $-2.85 Million | $16.37 Million | ▲ +43.5% |
| 2022 | -0.31x | $-4.24 Million | $-4.33 Million | $13.83 Million | ▲ +89.2% |
| 2021 | -2.84x | $-2.97 Million | $-3.25 Million | $1.05 Million | ▼ -19272.8% |
| 2020 | -0.01x | $-1.14K | $-1.14K | $78.03K | ▲ +99.7% |
| 2019 | -5.54x | $-120.46K | $-121.98K | $21.72K | ▼ -54.7% |
| 2018 | -3.58x | $-71.99K | $-71.99K | $20.09K | ▲ +71.5% |
| 2017 | -12.59x | $-320.34K | $-320.34K | $25.44K | — |